journal article Open Access Nov 01, 2022

Natural history of hypertrophic cardiomyopathy in cats from rehoming centers: The CatScan II study

View at Publisher Save 10.1111/jvim.16576
Abstract
Abstract

Background
The natural history of hypertrophic cardiomyopathy (HCM) in cats has been mainly studied in cats referred for suspected heart disease, which can skew the results towards cats with clinical signs. Few data are available on factors associated with development of HCM in cats.


Hypotheses
(1) Clinical variables can predict which cats will develop HCM; (2) HCM in cats not referred for suspected heart disease is associated with a low rate of cardiovascular events.


Animals
One hundred seven cats from rehoming centers without a history of clinical signs of cardiac or systemic disease at the time of adoption.


Methods
Prospective longitudinal study. After rehoming, shelter cats were reexamined for serial echocardiograms. Cox regression analysis was used to identify predictors of development of HCM in cats that were normal at baseline. Adverse cardiovascular events including heart failure, thromboembolism, or sudden death were recorded.


Results
Cats were monitored for a median of 5.6 [1.2-9.2] years. At baseline, 68/107 cats were normal, 18/107 were equivocal and 21/107 had HCM. Nineteen cats developed HCM during the study period. The factors at baseline associated with increased hazard of developing HCM were lower left atrial fractional shortening, higher left ventricular fractional shortening, and higher body weight. Cardiovascular events were observed in 21% of cats with HCM.


Conclusions and Clinical Importance
Cardiovascular events were common in cats with HCM from a rehoming center study sample. Lower left atrial systolic function appears to precede overt HCM.
Topics

No keywords indexed for this article. Browse by subject →

References
65
[1]
Hardarson "Prognosis and mortality of hypertrophic obstructive cardiomyopathy" Lancet (1973) 10.1016/s0140-6736(73)92730-x
[2]
McKenna "Hypertrophic cardiomyopathy: an important cause of sudden death" Arch Dis Child (1984) 10.1136/adc.59.10.971
[3]
Hecht "Clinical course of middle-aged asymptomatic patients with hypertrophic cardiomyopathy" Am J Cardiol (1992) 10.1016/0002-9149(92)90796-2
[4]
Fox "Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy: an animal model of human disease" Circulation (1995) 10.1161/01.cir.92.9.2645
[5]
Atkins "Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985-1989)" J Am Vet Med Assoc (1992) 10.2460/javma.1992.201.04.613
[6]
Rush "Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999)" J Am Vet Med Assoc (2002) 10.2460/javma.2002.220.202
[7]
Payne "Population characteristics and survival in 127 referred cats with hypertrophic cardiomyopathy (1997 to 2005)" J Small Anim Pr (2010) 10.1111/j.1748-5827.2010.00989.x
[9]
Cecchi "Hypertrophic cardiomyopathy in tuscany: clinical course and outcome in an unselected regional population" J Am Coll Cardiol (1995) 10.1016/0735-1097(95)00353-3
[10]
Spirito "Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population" N Engl J Med (1989) 10.1056/nejm198903233201201
[11]
Maron "Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history" Am J Cardiol (1993) 10.1016/0002-9149(93)91117-z
[12]
Maron "Clinical course of hypertrophic cardiomyopathy in a regional United States cohort" JAMA (1999) 10.1001/jama.281.7.650
[13]
Cannan "Natural history of hypertrophic cardiomyopathy: a population-based study, 1976 through 1990" Circulation (1995) 10.1161/01.cir.92.9.2488
[14]
Ho "The burden of early phenotypes and the influence of wall thickness in hypertrophic cardiomyopathy mutation carriers: findings from the HCMNet study" JAMA Cardiol (2017) 10.1001/jamacardio.2016.5670
[15]
Maurizi "Clinical course and significance of hypertrophic cardiomyopathy without left ventricular hypertrophy" Circulation (2019) 10.1161/circulationaha.118.037264
[16]
Ho "Evolution of hypertrophic cardiomyopathy in sarcomere mutation carriers" Heart (2016) 10.1136/heartjnl-2016-310015
[17]
Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study)

Jessie Rose Payne, David Charles Brodbelt, Virginia Luis Fuentes

Journal of Veterinary Cardiology 2015 10.1016/j.jvc.2015.03.008
[18]
ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats

Virginia Luis Fuentes, Jonathan Abbott, Valérie Chetboul et al.

Journal of Veterinary Internal Medicine 2020 10.1111/jvim.15745
[19]
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Roberto M. Lang, Luigi P. Badano, Victor Mor-Avi et al.

European Heart Journal - Cardiovascular Imaging 2015 10.1093/ehjci/jev014
[20]
Abbott "Two-dimensional echocardiographic assessment of the feline left atrium" J Vet Intern Med (2006)
[21]
Schober "Diagnostic accuracy of electrocardiography and thoracic radiography in the assessment of left atrial size in cats: comparison with transthoracic 2-dimensional echocardiography" J Vet Intern Med (2007) 10.1111/j.1939-1676.2007.tb03012.x
[22]
Taylor "ISFM consensus guidelines on the diagnosis and management of hypertension in cats" J Feline Med Surg (2017) 10.1177/1098612x17693500
[23]
Wilkie "Cardiac pathology findings in 252 cats presented for necropsy; a comparison of cats with unexpected death versus other deaths" J Vet Cardiol (2015) 10.1016/j.jvc.2015.09.006
[24]
Egenvall "Morbidity of insured Swedish cats during 1999-2006 by age, breed, sex, and diagnosis" J Feline Med Surg (2010) 10.1016/j.jfms.2010.08.008
[25]
Spruance "Hazard ratio in clinical trials" Antimicrob Agents Chemother (2004) 10.1128/aac.48.8.2787-2792.2004
[26]
Prevalence of cardiomyopathy in apparently healthy cats

Christopher F. Paige, Jonathan A. Abbott, François Elvinger et al.

Journal of the American Veterinary Medical Associa... 2009 10.2460/javma.234.11.1398
[27]
Comparison of auscultatory and echocardiographic findings in healthy adult cats

Tobias Wagner, Virginia Luis Fuentes, Jessie Rose Payne et al.

Journal of Veterinary Cardiology 2010 10.1016/j.jvc.2010.05.003
[28]
Zou "Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults" Am J Med (2004) 10.1016/j.amjmed.2003.05.009
[29]
Ho "Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy" Circulation (2002) 10.1161/01.cir.0000019070.70491.6d
[30]
Farhad "Left atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy" J Cardiovasc Magn Reson (2017) 10.1186/s12968-017-0420-0
[31]
Ho "Hypertrophic cardiomyopathy: preclinical and early phenotype" J Cardiovasc Transl Res (2009) 10.1007/s12265-009-9124-7
[32]
Nagueh "Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease" Circulation (2003) 10.1161/01.cir.0000084500.72232.8d
[33]
Gray "Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy" Int J Cardiol (2011) 10.1016/j.ijcard.2011.07.095
[34]
Captur "Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy" Circ Cardiovasc Imaging (2014) 10.1161/circimaging.114.002411
[35]
Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy

Martin S. Maron, Iacopo Olivotto, Caitlin Harrigan et al.

Circulation 2011 10.1161/circulationaha.110.985812
[36]
Ho "Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy" N Engl J Med (2010) 10.1056/nejmoa1002659
[37]
Ho "T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy" Circ Cardiovasc Imaging (2013) 10.1161/circimaging.112.000333
[38]
Sampedrano "Prospective echocardiography and tissue doppler imaging screening of a population of Maine coon cats tested for the A31P mutation in the myosin-binding protein c gene: a specific analysis of the heterozygous status" J Vet Intern Med (2009) 10.1111/j.1939-1676.2008.0218.x
[39]
Seo "Anterior mitral valve leaflet length in cats with hypertrophic cardiomyopathy" J Vet Cardiol (2021) 10.1016/j.jvc.2021.09.001
[40]
Marques-Alves "Atrial mechanics in hypertrophic cardiomyopathy: discriminating between ventricular hypertrophy and fibrosis" Arq Bras Cardiol (2022)
[41]
Fries "Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy" J Vet Intern Med (2021) 10.1111/jvim.16067
[42]
Borgeat "The influence of clinical and genetic factors on left ventricular wall thickness in ragdoll cats" J Vet Cardiol (2015) 10.1016/j.jvc.2015.06.005
[43]
Khor "Myocardial collagen deposition and inflammatory cell infiltration in cats with pre-clinical hypertrophic cardiomyopathy" Vet J (2015) 10.1016/j.tvjl.2014.11.018
[44]
Payne "Prognostic indicators in cats with hypertrophic cardiomyopathy" J Vet Intern Med (2013) 10.1111/jvim.12215
[45]
Debonnaire "Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation" Circ Arrhythmia Electrophysiol (2017) 10.1161/circep.116.004052
[46]
De "Subclinical echocardiographic abnormalities in phenotype-negative carriers of myosin-binding protein C3 gene mutation for hypertrophic cardiomyopathy" Am Heart J (2011) 10.1016/j.ahj.2011.05.018
[47]
Rüssel "Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness" J Cardiovasc Magn Reson (2011) 10.1186/1532-429x-13-3
[48]
Forsey "Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging" J Am Soc Echocardiogr (2014) 10.1016/j.echo.2013.10.012
[49]
Green "Heart disease: a small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice" Science (2016) 10.1126/science.aad3456
[50]
Stern "A small molecule inhibitor of sarcomere contractility acutely relieves left ventricular outflow tract obstruction in feline hypertrophic cardiomyopathy" PLoS One (2016) 10.1371/journal.pone.0168407

Showing 50 of 65 references

Metrics
25
Citations
65
References
Details
Published
Nov 01, 2022
Vol/Issue
36(6)
Pages
1900-1912
License
View
Funding
Petplan Charitable Trust
Everts Luff Feline Endowment
Cite This Article
Jose Novo Matos, Jessie Rose Payne, Joonbum Seo, et al. (2022). Natural history of hypertrophic cardiomyopathy in cats from rehoming centers: The CatScan II study. Journal of Veterinary Internal Medicine, 36(6), 1900-1912. https://doi.org/10.1111/jvim.16576